TEVA PHARMACEUTICAL INDUSTRIES LTD

By person

23 insiders · 54 transactions

25.8×

Richard Francis holds 25.8 times base salary in stock. $43.86M of shares against $1.70M in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Francis last reported holding, valued at $37.25, the price Ordinary Shares was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Francis Richard D

President and CEO

—

$31.26M (7) scheduled

−$31.26M

1,177,529

0.1010%

$43.86M

+855.1%

Kalif Eliyahu Sharon

EVP, Chief Financial Officer

—

$20.73M (3) scheduled

−$20.73M

65,621

0.0056%

$2.44M

−67.8%

Sabag Mark

See "Remarks"

—

$13.15M (4)

−$13.15M

80,760

0.0069%

$3.01M

−78.9%

Daniell Richard

EVP, Europe Commercial

—

$12.08M (8) scheduled

−$12.08M

55,755

0.0048%

$2.08M

—

MIGNONE ROBERTO

Director

—

$8.46M (3)

−$8.46M

487,407

0.0418%

$18.16M

−54.7%

Hughes Eric A

See "Remarks"

—

$4.17M (5) scheduled

−$4.17M

134,877

0.0116%

$5.02M

—

Fox Christine

EVP, U.S. Commercial

—

$2.75M (5)

−$2.75M

63,647

0.0055%

$2.37M

—

Lippman Evan

EVP, Business Development

—

$2.16M (3) scheduled

−$2.16M

25,591

0.0022%

$953.26K

—

Weiss Amir

Chief Accounting Officer

—

$1.41M (5)

−$1.41M

13,071

0.0011%

$486.89K

+152.4%

Shields Matthew

EVP, Global Operations

—

$1.40M (3) scheduled

−$1.40M

0.0000%

$0.00

—

Jover Placid

See "Remarks"

—

$895.46K (2) scheduled

−$895.46K

6,774

0.0006%

$252.33K

—

Savage Brian

Interim Chief Legal Officer

—

$163.76K (4) scheduled

−$163.76K

10,914

0.0009%

$406.55K

+1,377%

Satchi-Fainaro Ronit

Director

—

$15.46K (1)

−$15.46K

111,986

0.0096%

$4.17M

+26.9%

Zaks Tal Zvi

Director

—

$592.71 (1)

−$592.71

73,247

0.0063%

$2.73M

+49.1%

Elstein Amir

Director

—

2,118,455

0.1818%

$78.91M

+1.2%

BARER SOL J

Director

—

448,011

0.0384%

$16.69M

+9.5%

LIEBERMAN GERALD M

Director

—

130,149

0.0112%

$4.85M

+22.8%

Crane Rosemary A

Director

—

127,739

0.0110%

$4.76M

+23.3%

Nisen Perry

Director

—

119,807

0.0103%

$4.46M

+25.2%

Vergis Janet S.

Director

—

73,697

0.0063%

$2.75M

+15.0%

Shalev Varda

Director

—

22,504

0.0019%

$838.27K

+74.8%

Lichtenstein Chen

Director

—

19,296

0.0017%

$718.78K

—

McAvoy David R.

EVP, Chief Legal Officer

—

13,027

0.0011%

$485.26K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Lippman Evan

17 Aug 2026

EVP, Business Development

Sold on a plan

18,600

$36.57

$680.29K

Kalif Eliyahu Sharon

11 Jun 2026

EVP, Chief Financial Officer

Sold on a plan

106,563

$34.10

$3.63M

Kalif Eliyahu Sharon

14 May 2026

EVP, Chief Financial Officer

Sold on a plan

153,251

$35.61

$5.46M

Kalif Eliyahu Sharon

26 Feb 2026

EVP, Chief Financial Officer

Sold on a plan

345,810

$33.64

$11.63M

Show all 54 transactions →

TEVA PHARMACEUTICAL INDUSTRIES LTD

By person

Individual transactions

What was left out